ALUMIS INC. (ALMS) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: AKKARAJU SRINIVAS — 3 open-market purchases between 2026-09-04 and 2026-09-08, totaling $8,267,413.
ALMS Insider Trading Activity
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
Insider
Role
Date
Shares
Value
AKKARAJU SRINIVAS
Insider
2026-09-08
48,066
$507,019
AKKARAJU SRINIVAS
Insider
2026-09-08
48,065
$507,009
AKKARAJU SRINIVAS
Insider
2026-09-08
273,291
$2,904,291
AKKARAJU SRINIVAS
Insider
2026-09-08
273,290
$2,904,280
AKKARAJU SRINIVAS
Insider
2026-09-04
220,070
$2,458,842
Hardiman Roy C.
Chief Business & Strategy Ofcr
2026-08-03
2,692
$70,988
Schroer John R.
Chief Financial Officer
2026-08-03
3,282
$86,546
Goldstein David M
Chief Scientific Officer
2026-08-03
2,596
$68,457
Drappa Jorn
Chief Medical Officer
2026-08-03
2,447
$64,527
Bradley Mark Christopher
Chief Development Officer
2026-08-03
2,572
$67,824
How Institutional Funds Moved on ALMS
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
Fund
Change
Quarter
NOVO HOLDINGS A/S
NOVO HOLDINGS A/S opened a new position worth $30,954,000.
2026-06-30
AyurMaya Capital Management Company, LP
AyurMaya Capital Management Company, LP increased this position by 28% ($333,527,745 -> $426,031,355).
2026-06-30
FMR LLC
FMR LLC increased this position by 680% ($21,450,875 -> $167,396,981).
2026-06-30
SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC increased this position by 28% ($139,785,175 -> $178,554,463).
2026-06-30
Foresite Capital Management V, LLC
Foresite Capital Management V, LLC increased this position by 28% ($129,910,800 -> $165,941,439).
2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC increased this position by 34% ($88,830,820 -> $118,629,882).
2026-06-30
Deep Track Capital, LP
Deep Track Capital, LP increased this position by 20% ($149,200,268 -> $178,648,422).
2026-06-30
venBio Partners LLC
venBio Partners LLC increased this position by 28% ($99,760,828 -> $127,429,401).
2026-06-30
Which Funds Hold ALMS
Largest reported positions as of 2026-06-30.
Fund
Value
Shares
AyurMaya Capital Management Company, LP
$426,031,355
15,139,707
Deep Track Capital, LP
$178,648,422
6,348,558
SAMSARA BIOCAPITAL, LLC
$178,554,463
6,345,219
FMR LLC
$167,396,981
5,948,720
Foresite Capital Management V, LLC
$165,941,439
5,896,995
venBio Partners LLC
$127,429,401
4,528,408
Foresite Capital Management VI LLC
$119,529,434
4,247,670
VANGUARD CAPITAL MANAGEMENT LLC
$118,629,882
4,215,703
Nextech Invest Ltd.
$99,643,684
3,540,998
Cormorant Asset Management, LP
$92,456,671
3,285,596
Data compiled from public SEC filings. This is informational reporting, not investment advice.
A fresh Form 4 filing shows Srinivas Akkaraju, an insider at Alumis Inc. (ALMS), purchased 273,291 shares on 2026-09-08 at $10.63 per share, an open-market transaction worth $2,904,290.79. Following the purchase, Akkaraju’s stake stands at 4,937,026 shares, held indirectly through a trust or entity structure rather than in his own name. The transaction is not … Read more
SR One Capital Management, LP is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This page tracks those disclosures over time, similar to how investors follow the largest hedge funds buying and selling names like UNH or watch a portfolio including cash evolve position by position. Each … Read more